In pharmaceutical advancements, reservoir transdermal patches represent a pioneering approach to delivering medications with precision, efficacy, and patient convenience. These patches utilize a sophisticated reservoir system that ensures the controlled release of active pharmaceutical ingredients (APIs) directly through the skin into the bloodstream, offering a myriad of benefits over traditional dosage forms. CD Formulation can provide professional reservoir transdermal patch development.
Fig.1 Illustrates various types of transdermal delivery patches: (a) Single-layer drug-in-adhesive patch;(b) Multi-layer drug-in adhesive patch; (c) Drug reservoir-in-adhesive patch; (d) Drug matrix-in-adhesive patch. (Naziya Shaikh, et al. 2024)
Reservoir-type transdermal patches refer to a class of patches in which drugs form drug reservoirs with osmotic enhancers, thickeners, or other excipients, seal them between the backing and the control film, and control the drug release rate through the controlled release film. Its structure is mainly composed of the backing layer, drug reservoir, controlled release film, adhesive layer, and anti-adhesive layer. The backing layer has a certain mechanical strength, can resist solvent erosion, and generally uses polyester film, polyethylene film, and polyvinylidene chloride copolymer materials; The drug reservoir is a drug-containing layer, and to facilitate production, thickeners or skeleton materials are generally added to make semi-solid; Controlled release film is more important, mainly used to control the release speed of drugs, the thickness is generally between 25-75 μm, the commonly used materials are porous polypropylene film, ethylene - vinyl acetate copolymer (EVA) controlled release film and polyethylene controlled release film. The main function of the adhesive layer is to ensure that the patch can be in close contact with the skin during use, so that the drug can be effectively transmitted to the skin surface, mainly using polyacrylate pressure-sensitive adhesive; The anti-stick layer is the release film that plays a protective role, which needs to be peeled off before use, mainly using silicified polyester film, fluorinated polyester film or silicified paper.
Fig.2 Advantages of Reservoir Transdermal Patches (CD Formulation)
Technology: Technology for reservoir transdermal patch development
Journal: IP Indian Journal of Clinical and Experimental Dermatology
IF: 1.9
Published: 2024
Results: Micro-reservoir transdermal patches integrate a drug reservoir with a matrix dispersion. The reservoir is created by suspending the drug in an aqueous solution of a hydrophilic polymer, followed by uniform dispersion of the drug suspension on a lipophilic polymer. This dispersion process involves high-shear mechanical force, leading to the formation of numerous microscopic, non-leachable spheres. Drug release from these patches follows a zero-order kinetic rate, ensuring a consistent drug level in the plasma. To maintain thermodynamic stability, crosslinking polymeric agents are typically included in the drug dispersion.
At CD Formulation, we excel in reservoir transdermal patch development, leveraging our expertise and state-of-the-art facilities to deliver innovative solutions tailored to meet the diverse needs of our partners and clients. If you have any needs, please do not hesitate to contact us, and our colleagues will contact you within three working days.
References